Stifel Financial
DNA icon

Stifel Financial’s Ginkgo Bioworks DNA Stock Holding History

Stifel Financial’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,496
Closed -$33.4K – 3389
2024
Q2 		$33.4K Sell
2,496
-3,138
-56% -$93.6K ﹤0.01% 3303
2024
Q1 		$261K Buy
5,634
+1,660
+42% +$85.9K ﹤0.01% 2981
2023
Q4 		$269K Buy
3,974
+301
+8% +$18.4K ﹤0.01% 2905
2023
Q3 		$266K Buy
3,673
+724
+25% +$57.9K ﹤0.01% 2851
2023
Q2 		$219K Buy
2,949
+468
+19% +$27.7K ﹤0.01% 2993
2023
Q1 		$132K Buy
2,481
+409
+20% +$25.9K ﹤0.01% 3133
2022
Q4 		$140K Buy
2,072
+359
+21% +$33K ﹤0.01% 3074
2022
Q3 		$214K Buy
1,713
+218
+15% +$26K ﹤0.01% 2906
2022
Q2 		$142K Buy
1,495
+489
+49% +$59.6K ﹤0.01% 3093
2022
Q1 		$162K Buy
+1,006
New +$196K ﹤0.01% 3183

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return